Thrive Earlier Detection

Wishing all of our Thrivers a relaxing holiday break to recharge and gear up for a great 2021. Happy Holidays!

This year, Thrive is contributing to @familyreach's "Hope for the Holidays," a program that provides cancer families with financial resources, because we believe everyone should have a holiday that is merry and bright. Consider joining us by donating here: familyreach.org/holidays/

This lung cancer awareness month, our co-founder and head of research & innovation @IsaacKinde emphasizes the importance of screening & the significant impact our blood test had in detecting lung cancer in our DETECT-A study. The future of #earlierdetection is within reach. #LCAM

“Years from now, deaths from pancreatic cancer will be less common and that’s going to be in large part due to earlier detection.” Thank you, Dr. Vogelstein. We are dedicated to making this happen. #itsabouttime @lustgartenfdn @hopkinskimmel

Our CMO @SamAsgarian_MD will be talking about the #earlydetection of cancer for the Precision Medicine Leaders Summit's virtual series on precision oncology. Learn more: precisionmedicineleaderssumm…

The cancer screening gap is growing. Earlier this year, we published peer-reviewed data demonstrating how we may begin to close this gap using our multi-cancer blood test.

We’re thrilled to announce the expansion of our leadership team including: ▪️@SamAsgarian_MD as chief medical officer ▪️Frank Diehl as EVP of product solutions ▪️@DCiarimboli as chief legal officer ▪️Read more: bit.ly/33fShWD

We are excited to announce the closing of our $257M Series B financing. Hear from our CFO @isaacro and new board member Eli Casdin about how this will enable the advancement of our blood test, CancerSEEK, to provide better outcomes for patients. thrivedetect.com/press-relea…

Our SVP of public policy and external affairs @BhanSeema wrote a piece for @BCBSAssociation's Progress Health newsletter, sharing Thrive's mission to save lives through earlier #cancerdetection. Read her thoughts here: bit.ly/30GizPe

#ICYMI: We published data in @sciencemagazine with @HopkinsMedicine and @Geisinger from the first ever interventional study using a blood test to screen for multiple cancers. Our test more than doubled the number of cancers detected by screening methods.